BioGaia AB (publ) (BIOG-B) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.050x

Based on the latest financial reports, BioGaia AB (publ) (BIOG-B) has a cash flow conversion efficiency ratio of 0.050x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr70.36 Million ≈ $7.57 Million USD) by net assets (Skr1.40 Billion ≈ $150.94 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See BioGaia AB (publ) (BIOG-B) balance sheet quality index to measure how much of total assets are equity-financed.

BioGaia AB (publ) - Cash Flow Conversion Efficiency Trend (2002–2025)

This chart illustrates how BioGaia AB (publ)'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Check how high is BioGaia AB (publ)'s earnings quality to evaluate the quality of earnings relative to operating cash generation.

BioGaia AB (publ) Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of BioGaia AB (publ) ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Jupiter Wagons Limited
NSE:JWL
-0.041x
Suofeiya Home Collection Co Ltd
SHE:002572
-0.038x
Tongyang Inc
KO:001525
-0.001x
Americas Silver Corp
TO:USA
-0.213x
Bolsa Mexicana de Valores S.A.B. de C.V
MX:BOLSAA
0.042x
Carlsberg Brewery Malaysia Bhd
KLSE:2836
0.636x
Anadolu Anonim Turk Sigorta Sti
IS:ANSGR
0.069x
Batisoke Soke Cimento Sanayi TAS
IS:BSOKE
0.033x

Annual Cash Flow Conversion Efficiency for BioGaia AB (publ) (2002–2025)

The table below shows the annual cash flow conversion efficiency of BioGaia AB (publ) from 2002 to 2025. For the full company profile with market capitalisation and key ratios, see BioGaia AB (publ) stock valuation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 Skr1.31 Billion
≈ $141.43 Million
Skr306.57 Million
≈ $32.99 Million
0.233x +7.75%
2024-12-31 Skr1.72 Billion
≈ $185.52 Million
Skr373.22 Million
≈ $40.16 Million
0.216x +3.19%
2023-12-31 Skr2.03 Billion
≈ $218.50 Million
Skr425.96 Million
≈ $45.84 Million
0.210x +29.74%
2022-12-31 Skr1.97 Billion
≈ $212.26 Million
Skr318.94 Million
≈ $34.32 Million
0.162x +36.82%
2021-12-31 Skr1.88 Billion
≈ $202.03 Million
Skr221.88 Million
≈ $23.88 Million
0.118x -6.72%
2020-12-31 Skr1.75 Billion
≈ $187.92 Million
Skr221.26 Million
≈ $23.81 Million
0.127x -56.48%
2019-12-31 Skr507.87 Million
≈ $54.66 Million
Skr147.85 Million
≈ $15.91 Million
0.291x -19.22%
2018-12-31 Skr508.12 Million
≈ $54.68 Million
Skr183.12 Million
≈ $19.71 Million
0.360x -24.90%
2017-12-31 Skr463.89 Million
≈ $49.92 Million
Skr222.62 Million
≈ $23.96 Million
0.480x +34.69%
2016-12-31 Skr415.18 Million
≈ $44.68 Million
Skr147.93 Million
≈ $15.92 Million
0.356x +20.03%
2015-12-31 Skr395.83 Million
≈ $42.60 Million
Skr117.50 Million
≈ $12.64 Million
0.297x -17.76%
2014-12-31 Skr344.59 Million
≈ $37.08 Million
Skr124.38 Million
≈ $13.39 Million
0.361x +45.81%
2013-12-31 Skr316.86 Million
≈ $34.10 Million
Skr78.44 Million
≈ $8.44 Million
0.248x -66.30%
2012-12-31 Skr456.79 Million
≈ $49.16 Million
Skr335.56 Million
≈ $36.11 Million
0.735x +132.47%
2011-12-31 Skr230.35 Million
≈ $24.79 Million
Skr72.79 Million
≈ $7.83 Million
0.316x -14.17%
2010-12-31 Skr187.32 Million
≈ $20.16 Million
Skr68.97 Million
≈ $7.42 Million
0.368x +11.31%
2009-12-31 Skr161.12 Million
≈ $17.34 Million
Skr53.29 Million
≈ $5.73 Million
0.331x +128.07%
2008-12-31 Skr132.42 Million
≈ $14.25 Million
Skr19.20 Million
≈ $2.07 Million
0.145x +170.52%
2007-12-31 Skr94.91 Million
≈ $10.21 Million
Skr5.09 Million
≈ $547.55K
0.054x +580.80%
2006-12-31 Skr74.53 Million
≈ $8.02 Million
Skr-831.00K
≈ $-89.43K
-0.011x +91.97%
2005-12-31 Skr71.78 Million
≈ $7.72 Million
Skr-9.97 Million
≈ $-1.07 Million
-0.139x -155.28%
2004-12-31 Skr91.50 Million
≈ $9.85 Million
Skr22.99 Million
≈ $2.47 Million
0.251x +27.74%
2003-12-31 Skr114.85 Million
≈ $12.36 Million
Skr22.59 Million
≈ $2.43 Million
0.197x -14.88%
2002-12-31 Skr127.99 Million
≈ $13.77 Million
Skr29.57 Million
≈ $3.18 Million
0.231x --

About BioGaia AB (publ)

ST:BIOG-B Sweden Drug Manufacturers - Specialty & Generic
Market Cap
$1.22 Billion
Skr11.38 Billion SEK
Market Cap Rank
#7958 Global
#123 in Sweden
Share Price
Skr115.50
Change (1 day)
-0.09%
52-Week Range
Skr93.65 - Skr134.90
All Time High
Skr427.58
About

BioGaia AB (publ), a healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand. It operates through Pediatrics, Adult Health, and Other segments. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well … Read more